SHPH — Shuttle Pharmaceuticals Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1757499 ·
Last close
$0.59
Market Cap
$3.43M
52W High
$1.19
52W Low
$0.50
ADV30
1,666,820
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,216,822 | -2,152,471 | 11,809,327 | 1,089,946 | 8,463,084 |
| Dec 2025 | 0 | — | -2,788,235 | -2,614,895 | 10,475,977 | 334,005 | 8,221,531 |
| Sep 2025 | 0 | — | -2,266,942 | -2,347,302 | 3,542,927 | 2,094,643 | 2,148,766 |
| Jun 2025 | 0 | — | -3,910,406 | -3,706,465 | 5,504,429 | 4,817,672 | 1,898,910 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,481,645
Investing CF
$-3,056,722
Financing CF
$10,952,228
CapEx
—
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-51.67
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-46,299,770
Inventory
—
Receivables
$0
ST Investments
$0
EBIT TTM
$-11,650,841
Pretax Income TTM
$-11,721,669
Interest Exp TTM
$70,828
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -11,916,824 | -11,721,669 | 10,475,977 | 8,221,531 | — | -9,481,645 |
| Dec 2024 | 0 | -7,696,170 | -9,144,797 | 2,506,290 | 1,797,138 | — | -7,327,230 |
| Dec 2023 | 0 | -5,892,382 | -6,592,723 | 5,951,736 | 1,895,965 | — | -5,581,147 |
| Dec 2022 | 0 | -2,343,826 | -4,996,069 | 8,653,545 | 975,676 | — | -2,666,411 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AZTR | Azitra, Inc. | $3.40M | $0.21 | — |
| BIXT | BIOXYTRAN, INC | $3.47M | $0.03 | — |
| AVCRF | Avricore Health Inc. | $3.29M | $0.03 | — |
| GRI | GRI Bio, Inc. | $3.61M | $2.04 | — |
| NXTS | Nexentis Technologies Inc. | $3.78M | $5.17 | — |
News headlines (Yahoo Finance, 1h cache)
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
2026-05-01 14:37 · Yahoo
RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-27 12:00 · Yahoo
Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-26 20:05 · Yahoo
E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering
2026-03-12 12:30 · Yahoo
Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
2026-03-06 13:00 · Yahoo
Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever
2026-01-13 21:00 · Yahoo
Shuttle Pharma Layers AI Into Its Big Oncology Push
2025-12-18 20:39 · Yahoo
Shuttle Pharmaceuticals Acquires AI Health Platform
2025-11-21 14:30 · Yahoo
Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00
2025-11-03 12:00 · Yahoo
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
2025-10-22 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.